Abstract: In addition to synapse loss, neurofibrillary tangles, and neurodegeneration, oxidative stress and amyloid β-peptide [Aβ] deposition are hallmarks of Alzheimer's disease [AD] brain. Our laboratory coupled these two characteristics of AD into a comprehensive model to account for the synapse loss and neurodegeneration in AD brain. This model combines much of the extant studies on AD and is based on oxidative stress associated with amyloid β-peptide. This review presents evidence in support of this model and provides insight into the molecular basis of this devastating dementing disorder.
INTRODUCTION
Three major pathological indices characterize Alzheimer's disease (AD) brain: senile plaques (SP), neurofibrillary tangles, and synapse loss [1, 2] , which are thought to underlie the principal clinical manifestations of AD, i.e., progressive loss of memory, cognition, speech, and normative behavior. The AD brain is under intense oxidative stress as manifested by increased protein oxidation, lipid peroxidation, free radical formation, advanced glycation endproducts, and DNA/RNA oxidation, among other biomarkers [3, 4] .
Accumulating research suggests that the main component of SP, amyloid β-peptide [Aβ ], is central to the pathogenesis of AD [5] . The 42-amino acid Aβ is formed by proteolytic cleavage of a transmembrane protein, amyloid precursor protein (APP) by two proteases, β-secretase and γ-secretase (Figure 1) . Mutations in the genes for APP, and presenilin-1, and presenilin-2 cause the familial form of the disease, and an overproduction of Aβ(1-42) is observed [5] . A major risk factor for AD is the presence of allele 4 of apolipoprotein E [5] . The amino acid sequence of Aβ (Table I) shows the purported redox metal ion binding sites (H6, 13, 14) and the single methionine at residue 35, both of which are discussed in detail below.
The oxidative stress under which AD brain exists and the central role of Aβ in the pathogenesis of the disorder were coupled into a model for neurodegeneration in AD brain: the Aβ(1-42) -associated free radical oxidative stress model for neurodegeneration in AD [4, [6] [7] [8] [9] [10] . This review *Address correspondence to this author at the Department of Chemistry; Center of Membrane Sciences; and Sanders-Brown Center on Aging, University of Kentucky, Lexington, KY 40506 USA; Phone: [859] 257-3184; Fax: [859] 257-5876; E-mail: dabcns@uky.edu presents the studies of this model and the insights into AD that the model provides. 
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The model (Figure 2) is consistent with the concept that Aβ is central to the oxidative stress and neurotoxicity in AD brain. Irrespective of the underlying basis of why elevated levels of Aβ arise (inheritance of defective genes, genetic predisposition, or sporadically), the increased levels of Aβ are hypothesized to insert as a small aggregate into the neuronal membrane. Lipid peroxidation, resulting from free radicals associated with Aβ(1-42), occurs from which direct damage to transmembrane proteins can result. Alternatively, reactive lipid peroxidation products, especially 4-hydroxy-2-nonenal (HNE) or 2-propen-1-al (acrolein), can bind by Michael addition to protein cysteine, histidine, or lysine residues, thereby altering their conformation and function [11] [12] [13] [14] . As a consequence, Ca 2+ dyshomeostasis occurs, leading eventually and inexorably to cell death. Mitochondrial dysfunction and induction of nitric oxide synthesase (iNOS) by Aβ(1-42) are posited. Superoxide radical and NO, that result from such processes, respectivly, react at a diffusion-controlled rate to form peroxynitrite, a neurotoxic species [15] . Elevated calcium ions cause free radical formation by swelling of mitochondria and endoplasmic reticulum, with subsequent release of superoxide and other radicals. Cytochrome c release from mitochondria causes activation of the caspase cascade, thereby initiating apoptosis. In addition, elevated Ca 2+ induces phospholipase A 2 (PLA 2 ) activation, and free fatty acids, which are capable of aggregating tau protein, the main constituent in NFT [2] , are liberated. Excess intracellular Ca 2+ can result from NMDA receptor activation, leading to free radicals [16] . Thus, the possibility of excitotoxic neuronal death, resulting from excess glutamate on the external side of neurons, especially when coupled with diminished glutamine synthetase (GS) activity or dysfunction of the glutamate transporter, is enhanced. Fibrillar aggregates of Aβ(1-42) can activate microglia [17] , which, in turn, release neuron-damaging free radicals in an inflammatory response. The model, the central focus of which is the oxidative stress and subsequent neurotoxicity induced by Aβ , is consonant with several mechanisms for neuronal death in AD brain.
EXPERIMENTAL SUPPORT OF THE MODEL Protein Oxidation Caused by Aβ β β β (1-42)
Protein oxidation, assessed by immunochemical detection of the hydrazone formed by reaction of 2,4-dinitrophenylhydrazine with carbonyl functional groups [14, 18] , is prominent in AD brain [19] [20] [21] . Free radical induced peptide backbone scission, oxidation of selective amino acid side chains, and covalent modification of proteins by reactive alkenals such as HNE and acrolein are the three major ways of introducing carbonyl groups into proteins following oxidative stress [14] .
Consistent with a free radical process involving Aβ , the chain-breaking antioxidant vitamin E blocks free radical formation, protein oxidation, lipid peroxidation, and cell death in hippocampal cultures treated with Aβ(1-42) [22] [23] [24] . Protein oxidation also was assessed in neurons treated with Aβ using histofluorescence methods, and propyl gallate, also a free radial scavenger, blocked this effect [25] . Supporting the role of free radicals associated with Aβ-induced protein oxidation, vitamin E inhibited the Aβ-induced loss of enzyme activity of creatine kinase (CK, BB isoform) [26] . The activity of CK is lower in AD brain than in control brain [19, 20] . Oxidation of GS by Aβ was indexed by analysis of the real time kinetics of spin label incorporation into this protein that contains 88 sulfhydryl groups [27] . The protein-specific spin label was covalently bound to oxidized GS at a considerably slower rate than in unoxidized GS. Similarly, highly purified GS isolated from AD brain incorporated the spin label at a slower rate than GS from control brain, consistent with the GS being oxidized in AD. Oxidation of both CK and GS in AD brain was confirmed directly using proteomics (see below). Addition of Aβ to GS lowered the rate of incorporation of the spin label into the protein, suggesting that this peptide caused oxidation of GS [27] . In AD brain, diminution of GS activity relative to that in control brain is found [19, 20] .
Lipid Peroxidation Caused by Aβ β β β
Lipid peroxidation induced by Aβ, and blocked by vitamin E, was shown using electron paramagnetic resonance (EPR) in conjunction with a paramagnetic, lipid-specific spin label [28] [29] [30] . Overexpression of bcl-2, an anti-apototic protein, bcl-2 prevented Aβ-induced lipid peroxidation [30] .
The reactive alkenals HNE and acrolein, found in excess in AD brain [31, 32] , react with protein-resident cysteine, histidine, or lysine residues by Michael addition (Figure 3 ) [11, 14] . Transmembrane proteins provide proximal targets for attack by HNE or acrolein [11, 12] , which are formed in the lipid bilayer. Direct evidence for HNE formation following Aβ(1-42) addition to neurons or synaptosomes has been reported [33, 34] . Other lipid peroxidation products, F2-isoprostanes, also are formed following addition of Aβ to cells [35] . Both Aβ and HNE bind to and alter the structure of synaptosomal membrane proteins [12, 36] , and both Aβ and HNE alter the function of ion-motive ATPases [37] [38] [39] , transporters for glucose [40] , glutamate [34, 40] , and polyamines [41] , and various G-protein coupled signal transduction pathways [42] . Both HNE and acrolein alter the conformation of membrane proteins, which likely is the cause of the altered function of transport proteins induced by these reactive products of lipid peroxidation [12, 13] .
The glutamate transporter Glt-1 [EAAT2] in AD brain is covalently adducted by HNE in excess compared to that in control brain [34] , with this oxidative modification likely explaining the reported loss of Glt-1 activity in AD [43] . The same result as in AD brain could be induced by addition of Aβ(1-42) to synaptosomal preparations [34] , consistent with the idea that Aβ(1-42)-induced lipid peroxidation results in HNE-induced modification of this glutamate transporter in AD brain. Moreover, in AD brain excess extracellular glutamate and resultant excitotoxicity, as sequelae to oxidative modification and loss of activity of Glt-1, and coupled to Aβ-induced inhibition of GS activity [19, 20, 27, 44, 45] , provide one mechanism for neurodegeneration in AD. Since glutamate-stimulated NMDA receptor activation leads to elevated intracellular Ca 2+ accumulation [16] , this glutamate-based excitotoxic mechanism is a means to account for increased intracellular Ca 2+ following Aβ addition to neurons, consistent with the model (Figure 2) .
Elevated in AD brain [32] , the reactive alkenal, acrolein, similar to HNE, inserts a carbonyl functionality to proteins upon binding (Figure 3) . Elevation of the endogenous antioxidant glutathione (GSH) in rodents eliminated the acrolein-induced increased carbonyl content in subsequently isolated synaptosomes [13] . This result is consistent with the notion that one strategy to potentially combat Aβ-induced oxidative stress and its sequelae is to increase the endogenous antioxidant content of neurons (particularly GSH [46] ) or increase the level of enzymes that inhibit oxidative stress, e.g., heme oxygenase [47] .
Of the three principal alleles of the lipoprotein, apolipoprotein E, apoE4 is a risk factor for AD [5] . Aβ(1-42) was added to synaptosomes from knock-in mice having human Apo E2, Apo E3, or Apo E4 [48] . In these ApoE knock-in mice, the mouse promoter is present, but the human gene replaces the mouse gene for Apo E; consequently, the normal level and location of Apo E is present, but of the human form, not the mouse form. Of the markers of oxidative stress determined, among which were DCF fluorescence (to measure ROS), protein carbonyls (to index protein oxidation), and TBARS (a crude measure of lipid peroxidation), all were more sensitive to Aβ(1-42) in synaptosomes from human Apo E4 mice than in those from human Apo E2 or Apo E3 animals [48] . Although there are other interpretations of these results, particularly those involving clearance, one interpretation of these findings is that Apo E4 may be a risk factor for AD because it is unable to handle the oxidative stress associated with Aβ relative to that of Apo E2 or Apo E3. This idea may be associated with the lack of SH groups in Apo E4, one consequence of which is decreased free radical scavenging potential, or to altered binding of Aβ(1-42) by ApoE4, thereby providing increased opportunity for Aβ(1-42)-induced oxidative stress.
After our publication of Aβ-induced lipid peroxidation [28] , others have reported that Aβ causes lipid peroxidation and that various antioxidants are effective in blocking this effect (extensively reviewed in [7] [8] [9] ). In contrast to the wide agreement of studies from many different laboratories, a few reports doubt the ability of Aβ to induce lipid peroxidation or lipid-soluble antioxidants to prevent this oxidation [49] [50] [51] . However, methodological differences, such as using 1-3-day old neuronal cultures to test Aβ, that because the full complement of important receptors and other factors require considerably longer to be expressed, may not reflect a good model for adult neuronal brain cells. The preponderance of the evidence supports a role for Aβ -induced lipid peroxidation that is also extensive in AD brain. Peroxynitrite 3-Nitrotyrosine, a marker for the presence of peroxynitrite, formed from NO and superoxide radical [15] , is elevated in AD brain [52, 53] . In the model for neurodegeneration in AD brain (Figure 2) , Aβ(1-42) (or its downstream effects) is hypothesized to cause mitochondrial dysfunction. This, in turn, leads to subsequent superoxide release. Also, i-NOS induction, with subsequent formation of NO, is stimulated by Aβ(1-42) or its effects. Peroxynitrite then leads to 3-nitrotyrosine formation. Peroxynitrite added to synaptosomes caused increased protein oxidation, indexed by increased protein carbonyls, that could be inhibited by glutathione [54] . Glutathione also prevented the extensive peroxynitrite-induced neuronal death in hippocampal neuronal culture [54] .
The Aβ(1-42)-associated free radical oxidative stress model for neurodegeneration in AD brain predicts that elevated intracellular calcium ions cause numerous destructive cellular processes to occur (proteolysis, phospholipid breakdown, mitochondrial swelling, apoptosis, and endonuclease activation, among others). When Aβ is added to neurons or glial cells in culture excess intracellular calcium is observed [55] , consistent with the notion that Aβ(1-42) may be responsible for similar events in AD brain. (Table I) , contributes to the oxidative stress and neurotoxic properties of this peptide. For example, if a single atom of Aβ(1-42) is changed, namely a carbon atom for the sulfur atom of the thioether of Met-35, the resulting norleucine (Nle) derivative of Aβ (1-42) with the same length and relative hydrophobicity as the native peptide, is, in contrast, no longer oxidative nor neurotoxic [56] . Further, C. elegans transgenic for human Aβ show increased protein oxidation, a finding that is abrogated if the codon for methionine is replaced by a codon of a different amino acid [56] , consistent with the notion that both in vitro and in vivo the single methionine residue of Aβ(1-42) is critically important to the oxidative stress and neurotoxic properties of the peptide. This notion is supported by several different observations. If Aβ(1-42) with the sulfur atom of Met35 already oxidized (methionine sulfoxide) [Aβ(1-42)M35SO] is added to neuronal cultures, no neuronal cell death nor protein oxidation occurs [57] . This and other studies led to our idea that the reactive form of methionine in Aβ(1-42) is the sulfur radical cation (Figure 4) . This species is capable of abstracting a labile H atom from a carbon atom adjacent to unsaturated carbon atoms on phospholipid acyl chains to form a carbon-centered radical that, in turn, will rapidly bind paramagnetic molecular oxygen to form a peroxyl free radical. The peroxyl radical can partake in subsequent chain reactions forming free radicals that can damage membrane components directly or yield reactive aldehydes, such as HNE or acrolein. The protonated sulfur atom of Aβ(1-42) has a pKa of -5; consequently, this thio acid will immediately lose the H + to a nearby base, resulting in methionine, i.e., the process is catalytic [57] (Figure 4) . . . . Fig. (4) . Oxidation of methionine to form a sulfuramyl free radical on the S atom and its subsequent reaction with labile H atoms on lipids (L-H) or proteins (P-H). The resulting lipid radical (L . ) binds paramagnetic oxygen, leading to a chain reaction to form lipid peroxidation and lipid peroxidation products, such as HNE. Protein radicals (P . ) also bind molecular oxygen leading to protein carbonyls. The acid formed on the S atom of Met in residue 35 of Aβ1-42) has a pK a of minus 5; thus, any base would immediately bind to this H + , leading to methionine in the Aβ(1-42) peptide, i.e., the process is proposed to be catalytic. The lack of such chemistry in the absence of the S-atom of methionine (norleucine) in Aβ(1-42) or absence of a helical secondary structure around Met-35 is consistent with this proposed mechanism. See text.
Aβ(1-42) in solution adopts an α-helical structure for the carboxy-terminal portion of the peptide, including the methionine at residue 35 [58, 59] . One of the properties of helices is to have an i-i+4 interaction. Accordingly, NMR data show that the peptide carbonyl of Ile31 is within a van der Waals distance from the sulfur atom of Met35. We hypothesized that this interaction, based on studies of model thioethers [60] , alters the electronic environment around the sulfur atom of Met35, making the sulfur prone to oxidation. Consistent with this notion, substitution of proline, a helixbreaking amino acid, for isoleucine in position 31 of Aβ showed that, in contrast to native Aβ(1-42), no protein oxidation nor neurotoxicity was found [61] . Thus, the oxidative stress and neurotoxic properties of Aβ(1-42) are presumed to emanate from both the chemistry of thioethers and the unique secondary structure of the peptide [61, 62] .
The model outlined in Figure 2 implies that lipid peroxidation induced by small aggregates of Aβ(1-42) is an early event in the oxidative stress and neurotoxic action of this toxic peptide. Consistent with this implication, substitution of aspartic acid for glycine in position 37 of Aβ(1-42) caused the Aβ(1-42)G37D to no longer be toxic nor oxidative to neurons [63] . We reasoned that the negative charge on Asp would force the methionine residue out of the low dielectric environment of the bilayer, thereby preventing lipid peroxidation. Thus, even though the chemistry associated with the structure of the peptide and the involvement of the methionine were theoretically possible, no target for lipid peroxidation was possible, since the peptide was outside the bilayer.
Aβ β β β (1-42) Neurotoxicity: Cu 2+ and Methionine
Redox metal ions have been invoked in the mechanisms of oxidative stress and neurotoxicity associated with Aβ(1-42) [64, 65] . The three histidine residues of Aβ(1-42) at positions 6,13,14 bind Cu 2 + , and the peptide is hypothesized to reduce this redox ion to Cu(I). Subsequent chemistry that has Cu + reacting with molecular oxygen in a two-electron process is postulated to form H 2 O 2 , which is suggested to react with Cu(I) to form the damaging hydroxyl radical [64, 65] . To investigate this postulated mechanism, and the potential role of the interaction between peptidebound Cu + and Met35, the norleucine derivative of Aβ , which, as noted above, lacks the methionine sulfur, but does contain the three Cu(II)-binding His residues, was neither oxidative nor neurotoxic, even in the presence of added Cu(II) [57] . In addition, Tyr, which binds Cu 2+ at least one hundred fold less avidly than does His, was substituted for the three His residues, and the resulting Aβ(1-42) modified peptide was still not toxic [57] . Thus, Cu 2+ conceivably may be important in Aβ(1-42)-induced oxidative stress and neurotoxicity, but if this is the case, the above studies suggest that Met is required. Consistent with this notion, others showed that the shorter fragment, Aβ , which still contains the three Cu 2+ -binding His residues, but not methionine, was not toxic and did not reduce Cu 2+ [66] . However, these researchers showed that addition of Met to the Aβ(1-28) preparation caused the reduction of Cu 2+ to Cu + and intercalation into the lipid bilayer [66] . As noted above, substitution of helix-breaking Ile at residue 31 or synthesis of the norleucine derivative at residue 35 of Aβ abrogates the oxidative stress and neurotoxic properties of this peptide in both cases, even though the three His Cu(II)-binding sites are still present in these modified peptides.
Iron(II) also can undergo Fenton-type chemistry, with H 2 O 2 , producing hydroxyl radicals. However, the normal state of iron is Fe 3+ , so a reductant is necessary to produce Fe 2+ . Ascorbate can serve this function, as can a number of other agents, including neuromelanin. Hence, in Parkinson's disease, excessively high iron content in the substantia nigra, where neuromelanin is extensively located, may be one source of the oxidative stress in this neurodegenerative disorder [67] . As a harder acid, Fe 3+ is much less likely to bind to His than is Cu 2+ . Hence, although the chemistry associated with Cu 2+/1+ and Aβ(1-42) noted above is theoretically possible with Fe 3+/2+ , the probability of this chemistry is lower due to the hardness of Fe 3+ relative to Cu 2+ and consequent decreased binding affinity for His.
Aβ β β β(1-42) Neurotoxicity and Fibril Formation
The presence of neuritic plaques in AD brain that are rich in aggregated Aβ is consistent with the idea that soluble Aβ monomers in the AD brain presumably aggregate to form oligomers or fibrils [68] . Indeed, soluble Aβ oligomers have been isolated from normal and AD brains [69] . In AD brain, the percentage of soluble Aβ to total Aβ is substantially increased relative to control brain, and the proportion of soluble Aβ(1-42) is increased over the shorter, soluble Aβ(1-40). Many laboratories have reported that low molecular weight oligomers of Aβ are neurotoxic [70] [71] [72] [73] [74] [75] [76] -40) and Aβ (25) (26) (27) (28) (29) (30) (31) (32) (33) (34) (35) form fibrillar structures upon incubation. Many reports show that Aβ(1-42) fibrils are not required for toxicity [70] [71] [72] [73] [74] [75] [76] , a finding confirmed by fibrilforming, non-neurotoxic, non-protein-oxidizing, and nonfree radical-forming Aβ (1-42)Met35Nle and Aβ(1 -42)M35SO [57] . Thus, studies with Aβ(1-42) suggest that while the methionine residue of this peptide, and possibly redox metal ions, are crucial for the peptide-induced neurotoxicity, fibril formation per se is not required for neurotoxicity. Rather, reports from many laboratories suggest that small aggregates of Aβ are likely the toxic species [72] [73] [74] [75] [76] [77] . Such small aggregates would be capable of inserting into the lipid bilayer to induce lipid peroxidation, while large fibrillar structures would have difficulty doing so. Consistent with the notion that small aggregates of Aβ are the toxic species of this peptide, we recently showed in living C . e l e g a n s engineered to have a temperature-sensitive human Aβ(1-42) expression system that oxidative stress occurred 24 hours after induction of the peptide expression, a time that exactly mirrored the phenotypic expression of the worm (paralysis) and in the absence of large fibrillar deposits [77] .
Oxidatively-Modified Proteins in AD Brain: Identification by Proteomics
Protein oxidation in AD brain regions where Aβ(1-42) is present, but not in Aβ(1-42)-poor cerebellum, is significant [19] . But, which particular proteins are oxidized? Identification of specifically oxidized proteins may give insight into loss of protein function and potential mechanisms of neuronal death in AD brain. As an initial step toward this end, immunochemical methods coupled to two-dimensional electrophoresis revealed that CK (BB isoform) and β-tubulin were specifically oxidized in AD brain [78, 79] . Though reliable, immunochemical detection of specifically oxidized proteins is labor-intensive, requires knowledge of the molecular weight and isoelectric point of unknown proteins, and requires availability of specific antibodies. Newer, data-based, automated methods of unknown protein identity are necessary to make the aim of identifying specifically oxidized proteins in AD brain feasible. We have begun this process using proteomics [80] [81] [82] [83] [84] . This mass spectrometric analysis of oxidized protein spots from a two-dimensional matrix, for the first time, has been used to identify oxidized proteins from AD brain. CK (BB isoform), GS, and ubiquitin carboxyl-terminal hydrolase L-1 (UCH), dihydropyrimindase related protein 2 (DRP-2), and α-enolase were found to be specifically oxidized in AD brain [80, 81] . Proteomic screening of AD brain to identify proteins posttranslationally modified as assessed by 3-nitrotyrosine, also revealed specific proteins: α-enolase, triosephosphate isomerase, and neuropolypeptide h3 [82] .
The proteomic identification of oxidized CK in AD brain [80] confirms the immunochemical identification of this oxidized protein [78, 79] . The low activity of CK in AD [19] likely reflects this oxidative modification. The other energyrelated enzymes, α-enolase and triosephosphate isomerase, identified as oxidatively modified in AD brain may, like CK, have decreased activity in AD brain as a consequence of its oxidation. Thus, the oxidation of these three energyrelated enzymes may contribute to the known decreased energy utilization in AD brain.
GS activity also is decreased in AD brain [19] , highly likely a consequence of its oxidation. In recollection of the oxidative modification and low activity of GLT-1 noted above [34, 43] , the oxidative modification and low activity of GS may contribute to an excitotoxic mechanism for neuronal death in AD brain. The recent success of memantine, a NMDA receptor antagonist, in late-stage AD patients [85] is consistent with this suggestion.
As proteins become damaged or oxidized, ubiquitin can be bound to them, marking them for degradation by the 26S proteasome [86, 87] . If oxidized UCH, like CK and GS, has low activity in AD brain, then recycling of ubiquitin will be inhibited. Increased protein ubiquitination, decreased activity of the proteasome, and accumulation of aggregated and damaged proteins would be predicted, and all are observed in AD brain. Additional studies in AD and rodent modes thereof, currently underway in our laboratory, will determine if this process is operative in AD.
Elongation and directionality of the dendritic growth cone is promoted by the protein collapsin, which in turn is regulated or influenced by DRP-2. Normally, this protein is expressed during development, but under conditions of neuronal loss, as in AD brain, its expression may be increased in adult brain as well. Should the function of DRP-2 be diminished as a consequence of its oxidation, shortened dendritic lengths and decreased interneuronal connections would be predicted. Shortened dendritic lengths are observed in AD brain [88] , and decreased network connections in neuronal cultures treated with Aβ are observed [26] . One could speculate that decreased cellular contact could affect neuronal signaling and processes associated with memory, the most prominent clinical presentation in AD. N e u r o p o l y p e p t i d e h 3 , a l s o k n o w n a s phosphatidylethanolamine binding protein [PEBP] or hippocampal cholinergic neurostimulating peptide [HCNP] , is oxidatively modified in AD brain [82] . Conceivably, oxidation of HCNP contributes to the known deficits of the cholinergic system in AD brain. In its role as PEBP, oxidation of this protein could, in principle, affect phospholipid asymmetry, loss of which would permit exposure of phosphatidylserine (PS) on the external lamellae of the neuronal lipid bilayer. Such an orientation of PS is a signal for apoptosis, which conceivably could contribute to neuronal death in AD brain.
Our proteomics analysis of posttranslationally modified proteins in AD brain continues and is expected to reveal new insights into potential mechanisms of synapse loss and neuronal death in AD brain.
CONCLUSION
Consistent with the Aβ-associated free radical oxidative stress model for neurodegeneration in AD brain [4, [6] [7] [8] [9] [10] , Aβ , in mechanisms that are inhibited by free radical antoxidants, induces ROS formation, protein oxidation, lipid peroxidation, and cell death in hippocampal neuronal cultures. Since Aβ(1-42) is likely central to the pathogenesis of AD, the oxidative stress and neurotoxic properties of this peptide presumably contribute to the oxidative stress, synapse loss, and neurodegeneration found in AD brain (see other recent reviews [89, 90] ). The oxidative stress and neurotoxic properties of Aβ(1-42) couple the centrality of Aβ to the pathogenesis of AD with the oxidative stress under which AD brain exists [3, [6] [7] [8] [9] [10] . The single methionine of Aβ(1-42) at position 35 is critical to the oxidative stress and neurotoxic properties of the peptide [56, 57, [61] [62] [63] , and may act mechanistically via the sulfur radical cation or a redox metal complex. The reactive alkenal, HNE, formed by Aβ(1-42) addition to neurons, reacts by Michael addition with crucial proteins in neuronal membranes, thereby changing their structure and function [11, 12, 34] . One such protein is GLT-1, a glial-resident glutamate transporter. Increased HNE binding to GLT-1 is found in AD brain [34] , probably accounting for decreased activity of this transporter [43] , and Aβ(1-42) leads to the same effect [34] . When coupled to loss of GS activity in AD brain [19, 20] or by Aβ [27, 45] , GLT-1 inhibition secondary to oxidative modification increases the possibility of excitotoxic neuronal death. Increased levels of glutathione protect brain membrane preparations against these reactive alkenals, suggesting that elevation of this endogenous antioxidant may be a promising therapeutic strategy for AD [13, 46, 54, 91, 92] . New insights into potential mechanisms of synapse loss and neurodegeneration in AD brain, based on identification of specifically oxidatively modified proteins using proteomics, have been gained [80] [81] [82] [83] [84] .
Extensive support for the amyloid β-peptide-associated free radical oxidative stress model for neurodegeneration in AD brain has been obtained and summarized here. These studies suggest that one therapeutic strategy for AD is to block oxidative stress associated with Aβ(1-42) using both exogenous and endogenous, brain-accessible antioxidants [23, 46] , taking into account the need to preserve normal free radical processes necessary for brain function. Studies along these lines are underway in many laboratories, including ours.
ACKNOWLEDGEMENTS
This work was supported in part by grants from NIH (AG-05119; AG-10836). The author thanks his past and present graduate students, postdoctoral fellows, and faculty colleagues, who have contributed to the results reviewed here. Ms. Mollie Fraim and Dr. Alessandra Castegna are acknowledged and thanked for their help in preparing this manuscript as is Ms. Marcia Butterfield for technical assistance. 
